These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1906109)

  • 21. Conformations of complexes between mitomycins and decanucleotides. 3. Sequence specificity, binding at C-10, and mitomycin analogues.
    Remers WA; Rao SN; Wunz TP; Kollman PA
    J Med Chem; 1988 Aug; 31(8):1612-20. PubMed ID: 3397999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antitumor activity of novel mitomycin derivatives containing functional groups at the C-6-methyl position.
    Arai H; Kanda Y; Ashizawa T; Morimoto M; Gomi K; Kono M; Kasai M
    J Med Chem; 1994 Jun; 37(12):1794-804. PubMed ID: 8021918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antitumor activity of a novel water soluble mitomycin analog; 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C.
    Kono M; Saitoh Y; Kasai M; Sato A; Shirahata K; Morimoto M; Ashizawa T
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1128-30. PubMed ID: 2766417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent advanced studies on mitomycins, antitumor activity and mode of action].
    Taguchi T; Morimoto M
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2396-409. PubMed ID: 3111386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of new mitomycin C and porfiromycin analogues.
    Iyengar BS; Lin HJ; Cheng L; Remers WA; Bradner WT
    J Med Chem; 1981 Aug; 24(8):975-81. PubMed ID: 7328599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems.
    Imai R; Morimoto M; Marumo H; Kobayashi T; Tsuruo T; Inaba M; Tsukagoshi S; Sakurai Y
    Gan; 1981 Dec; 72(6):944-9. PubMed ID: 6804296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH; Singh SV
    Cancer Res; 1992 Dec; 52(23):6666-70. PubMed ID: 1423311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antineoplastic activity of C7-substituted mitomycin C analogues MC-77 and MC-62 against human breast-cancer cell lines.
    Ghiorghis A; Talebian A; Clarke R
    Cancer Chemother Pharmacol; 1992; 29(4):290-6. PubMed ID: 1537075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The derivation of 1a-demethylmitomycin G from mitomycin C.
    Kono M; Kasai M; Shirahata K; Morimoto M
    J Antibiot (Tokyo); 1990 Apr; 43(4):383-90. PubMed ID: 2112532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New sugar mitomycin C analogues: preparation, murine P388 antitumor activity, and leukopenia induction.
    Talebian A; Green D; Hammer CF; McPherson E; Schein PS
    J Pharm Sci; 1990 Dec; 79(12):1105-8. PubMed ID: 2127804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reassignment of the structure for the antitumor agent RR-150.
    Senter PD; Langley DR; Manger WE; Vyas DM
    J Antibiot (Tokyo); 1988 Feb; 41(2):199-201. PubMed ID: 3356608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of lipophilicity in the in vitro antitumour activity of a series of new mitosene compounds.
    Maliepaard M; de Mol NJ; Janssen LH; van der Neut W; Verboom W; Reinhoudt DN
    Anticancer Drug Des; 1992 Oct; 7(5):415-25. PubMed ID: 1388632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.
    Bradner WT; Rose WC; Schurig JE; Florczyk AP; Huftalen JB; Catino JJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6475-81. PubMed ID: 3933826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiotoxicity of mitomycin A, mitomycin C, and seven N7 analogs in vitro.
    Dorr RT; Shipp NG; Liddil JD; Iyengar BS; Kunz KR; Remers WA
    Cancer Chemother Pharmacol; 1992; 31(1):1-5. PubMed ID: 1458553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of lipophilic prodrugs of mitomycin C entrapped in liposome or O/W emulsion.
    Sasaki H; Takakura Y; Hashida M; Kimura T; Sezaki H
    J Pharmacobiodyn; 1984 Feb; 7(2):120-30. PubMed ID: 6427444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure studies of mitomycins. III. Structure of M-83.
    Hirayama N
    Acta Crystallogr C; 1990 Oct; 46 ( Pt 10)():1962-4. PubMed ID: 2257113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antitumor activity of various 6-demethylmitomycins and 6-demethyl-6-halomitomycins.
    Arai H; Ashizawa T; Gomi K; Kono M; Saito H; Kasai M
    J Med Chem; 1995 Aug; 38(16):3025-33. PubMed ID: 7636865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9.
    Fitzsimmons SA; Workman P; Grever M; Paull K; Camalier R; Lewis AD
    J Natl Cancer Inst; 1996 Mar; 88(5):259-69. PubMed ID: 8614004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential antitumor agents. 47. 3'-Methylamino analogues of amsacrine with in vivo solid tumor activity.
    Atwell GJ; Baguley BC; Finlay GJ; Rewcastle GW; Denny WA
    J Med Chem; 1986 Sep; 29(9):1769-76. PubMed ID: 3755758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.